Mindray Medical (MR) Tops Q3 EPS by 3c; Announces $100M Buyback Program
Tweet
Share
E-mailGet Alerts MR Hot Sheet
Join SI Premium – FREE
Mindray Medical International (NYSE: MR) reported Q3 EPS of $0.36, $0.03 better than the analyst estimate of $0.33. Revenue for the quarter came in at $218.4 million versus the consensus estimate of $197.94 million.
Authorizes a $100 million buyback program.
Authorizes a $100 million buyback program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
- Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
- Digimarc Corporation (DMRC) Tops Q2 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
